NewsBenzinga礼来公布评估 Foundayo 疗效和安全性的 3 期 ACHIEVE-4 试验详细结果；与甘精胰岛素相比，Foundayo 的 MACE-4 风险降低 16%，MACE-3 风险降低 23%，达到非劣效性的主要目标 礼来公布评估 Foundayo 疗效和安全性的 3 期 ACHIEVE-4 试验详细结果；与甘精胰岛素相比，Foundayo 的 MACE-4 风险降低 16%，MACE-3 风险降低 23%，达到非劣效性的主要目标 Benzinga 2026.09.30 22:04 (GMT+0) Open on Benzinga Other news $100 Invested In TD Synnex 10 Years Ago Would Be Worth This Much Today Google releases Gemini 4 Argon, called its most powerful model yet If You Invested $100 In Encompass Health Stock 15 Years Ago, You Would Have This Much Today This Healthcare Stock Just Raised Its Dividend by Nearly 15%. If You Invested $1000 In Waters Stock 20 Years Ago, You Would Have This Much Today Adicet Bio, Inc. (ACET) Discusses Positive Prula-cel Data and Plans for Pivotal Study in Lupus Nephritis - Slideshow (NASDAQ:ACET) 2026-09-30
Adicet Bio, Inc. (ACET) Discusses Positive Prula-cel Data and Plans for Pivotal Study in Lupus Nephritis - Slideshow (NASDAQ:ACET) 2026-09-30
